Naresh Rohilla

Naresh Rohilla

Active Director Director DIN 09291150
DIN 09291150 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Naresh Rohilla

Data last updated:

Naresh Rohilla is a Director at Medflix Biomedical India Private Limited (since 2021). The company operates in Healthcare. Medflix Biomedical India Private Limited reported revenue of ₹4.64 Cr (FY 2025).

DIN 09291150
Primary Designation Director
Industry Healthcare
First Appointment 24 Aug 2021
Oldest Company Age 5 yrs
Largest company Medflix Biomedical India Private Limited · ₹4.64 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Aug 20212021₹4.64 Cr (FY 2025)Active

Board colleagues of Naresh Rohilla

Directorship timeline

Open interactive timeline →
Medflix Biomedical India Private Limited
Premium access

Shareholding and investment profile for Naresh Rohilla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Rohilla

Naresh Rohilla currently holds 1 directorship: Medflix Biomedical India Private Limited (Director, since 24 Aug 2021, revenue ₹4.64 Cr (FY 2025)).

Naresh Rohilla was first appointed on 24 Aug 2021 as Director at Medflix Biomedical India Private Limited.

The current boards of Naresh Rohilla's companies include Ankur Kamboj (Medflix Biomedical India Private Limited), Manohar Lal (Medflix Biomedical India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available